Literature DB >> 25479750

Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.

Lei Ye1, Ying-Hua Chang2, Qiang Xiong3, Pengyuan Zhang3, Liying Zhang3, Porur Somasundaram3, Mike Lepley4, Cory Swingen3, Liping Su3, Jacqueline S Wendel5, Jing Guo3, Albert Jang6, Daniel Rosenbush3, Lucas Greder7, James R Dutton7, Jianhua Zhang8, Timothy J Kamp9, Dan S Kaufman4, Ying Ge10, Jianyi Zhang11.   

Abstract

Human induced pluripotent stem cells (hiPSCs) hold promise for myocardial repair following injury, but preclinical studies in large animal models are required to determine optimal cell preparation and delivery strategies to maximize functional benefits and to evaluate safety. Here, we utilized a porcine model of acute myocardial infarction (MI) to investigate the functional impact of intramyocardial transplantation of hiPSC-derived cardiomyocytes, endothelial cells, and smooth muscle cells, in combination with a 3D fibrin patch loaded with insulin growth factor (IGF)-encapsulated microspheres. hiPSC-derived cardiomyocytes integrated into host myocardium and generated organized sarcomeric structures, and endothelial and smooth muscle cells contributed to host vasculature. Trilineage cell transplantation significantly improved left ventricular function, myocardial metabolism, and arteriole density, while reducing infarct size, ventricular wall stress, and apoptosis without inducing ventricular arrhythmias. These findings in a large animal MI model highlight the potential of utilizing hiPSC-derived cells for cardiac repair.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25479750      PMCID: PMC4275050          DOI: 10.1016/j.stem.2014.11.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  29 in total

1.  Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.

Authors:  Qiang Xiong; Lei Ye; Pengyuan Zhang; Michael Lepley; Cory Swingen; Liying Zhang; Dan S Kaufman; Jianyi Zhang
Journal:  Circ Res       Date:  2012-06-21       Impact factor: 17.367

2.  Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.

Authors:  Andrew Wilber; Jonathan L Linehan; Xinghui Tian; Petter S Woll; Julie K Morris; Lalitha R Belur; R Scott McIvor; Dan S Kaufman
Journal:  Stem Cells       Date:  2007-08-02       Impact factor: 6.277

3.  Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces.

Authors:  Tatsuya Shimizu; Masayuki Yamato; Yuki Isoi; Takumitsu Akutsu; Takeshi Setomaru; Kazuhiko Abe; Akihiko Kikuchi; Mitsuo Umezu; Teruo Okano
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

4.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

5.  Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells.

Authors:  Petter S Woll; Julie K Morris; Matt S Painschab; Rebecca K Marcus; Aimee D Kohn; Travis L Biechele; Randall T Moon; Dan S Kaufman
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

6.  Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

Authors:  Oren Caspi; Irit Huber; Izhak Kehat; Manhal Habib; Gil Arbel; Amira Gepstein; Lior Yankelson; Doron Aronson; Rafael Beyar; Lior Gepstein
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

Review 7.  Critical roles for thrombin in acute and chronic inflammation.

Authors:  D Chen; A Dorling
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents.

Authors:  Linda W van Laake; Robert Passier; Pieter A Doevendans; Christine L Mummery
Journal:  Circ Res       Date:  2008-04-24       Impact factor: 17.367

9.  Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Authors:  Katherine L Hill; Petra Obrtlikova; Diego F Alvarez; Judy A King; Susan A Keirstead; Jeremy R Allred; Dan S Kaufman
Journal:  Exp Hematol       Date:  2010-01-11       Impact factor: 3.084

10.  Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.

Authors:  Xian-Liang Tang; Gregg Rokosh; Santosh K Sanganalmath; Fangping Yuan; Hiroshi Sato; Jianyao Mu; Shujing Dai; Chengxin Li; Ning Chen; Yong Peng; Buddhadeb Dawn; Greg Hunt; Annarosa Leri; Jan Kajstura; Sumit Tiwari; Gregg Shirk; Piero Anversa; Roberto Bolli
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more
  189 in total

Review 1.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

2.  Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids.

Authors:  Yu Tan; Dylan Richards; Robert C Coyle; Jenny Yao; Ruoyu Xu; Wenyu Gou; Hongjun Wang; Donald R Menick; Bozhi Tian; Ying Mei
Journal:  Acta Biomater       Date:  2017-01-10       Impact factor: 8.947

3.  3-Dimensionally Printed, Native-Like Scaffolds for Myocardial Tissue Engineering.

Authors:  Alexa Wnorowski; Joseph C Wu
Journal:  Circ Res       Date:  2017-04-14       Impact factor: 17.367

Review 4.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

5.  Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Won Hee Lee; Wen-Yi Chen; Ning-Yi Shao; Dan Xiao; Xulei Qin; Natalie Baker; Hye Ryeong Bae; Tzu-Tang Wei; Yongjun Wang; Praveen Shukla; Haodi Wu; Kazuki Kodo; Sang-Ging Ong; Joseph C Wu
Journal:  Stem Cells       Date:  2017-07-31       Impact factor: 6.277

6.  Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Authors:  Oscar J Abilez; Evangeline Tzatzalos; Huaxiao Yang; Ming-Tao Zhao; Gwanghyun Jung; Alexander M Zöllner; Malte Tiburcy; Johannes Riegler; Elena Matsa; Praveen Shukla; Yan Zhuge; Tony Chour; Vincent C Chen; Paul W Burridge; Ioannis Karakikes; Ellen Kuhl; Daniel Bernstein; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Stem Cells       Date:  2017-11-13       Impact factor: 6.277

7.  Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.

Authors:  Masashi Kawamura; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Koichi Toda; Takashi Daimon; Tatsuya Shimizu; Teruo Okano; Yoshiki Sawa
Journal:  Tissue Eng Part A       Date:  2015-07-14       Impact factor: 3.845

8.  Heart regeneration in mouse and human: A bioengineering perspective.

Authors:  Barry Fine; Gordana Vunjak-Novakovic
Journal:  Curr Opin Physiol       Date:  2020-01-09

Review 9.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

10.  Multi-Material Tissue Engineering Scaffold with Hierarchical Pore Architecture.

Authors:  Kathy Ye Morgan; Demetra Sklaviadis; Zachary L Tochka; Kristin M Fischer; Keith Hearon; Thomas D Morgan; Robert Langer; Lisa E Freed
Journal:  Adv Funct Mater       Date:  2016-06-13       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.